Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Lablytica Life Science: We Know Science

## Sitemaps
[XML Sitemap](https://lablytica.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Inlägg
- [Svar Life Science & Lablytica Life Science Announce Strategic Partnership to Expand Bioanalytical Services with Advanced LC-MS/MS Capabilities](https://lablytica.com/svar-life-science-lablytica-life-science-announce-strategic-partnership-to-expand-bioanalytical-services-with-advanced-lc-ms-ms-capabilities/): We are proud to announce our new partnership with Svar Life Science AB, a leading provider of bioanalytical and diagnostic solutions, based in Malmö, Sweden.
- [Lablytica exhibition at KI Science Park DAY](https://lablytica.com/lablytica-exhibition-at-ki-science-park-day/): Lablytica will have an exhibition at KI Science Park DAY hosted by KI Science Park in Solna this Wednesday.
- [Lablytica is a proud sponsor of the 17th Symposium on Pharmacokinetics and Drug Metabolism](https://lablytica.com/lablytica-is-a-proud-sponsor-of-the-17th-symposium-on-pharmacokinetics-and-drug-metabolism/): Lablytica is a proud sponsor of the 17th Symposium on Pharmacokinetics and Drug Metabolism arranged by Läkemedelsakademin in Mölndal on November 12-13, 2024
- [CTR launches podcast together with SwedenBIO](https://lablytica.com/ctr-launches-podcast-together-with-swedenbio/): The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12.
- [CTR acquires preclinical toxicology company](https://lablytica.com/ctr-acquires-preclinical-toxicology-company/): Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR.
- [New statement of OECD GLP compliance](https://lablytica.com/lablytica-has-received-their-new-statement-of-oecd-glp-compliance/): Happy and proud to share that Lablytica has just received their new statement of OECD GLP compliance for Analytical and Clinical Chemistry testing (8) from SWEDACs inspection on the 10 November 2020.
- [Karin Meyer blir ny VD för Center for Translational Research Sweden AB (CTR)](https://lablytica.com/karin-meyer-blir-ny-vd-for-center-for-translational-research-sweden-ab-ctr/): CTR tillkännager att styrelsen har utsett Karin Meyer till ny verkställande direktör. Karin Meyer efterträder Mats Lindquist som varit verkställande direktör sedan starten av CTR 2016.
- [David Pekar becomes CEO at Lablytica](https://lablytica.com/david-pekar-becomes-ceo-at-lablytica/): Lablytica Life Science AB started in November 2019 when Recipharm’s GLP bioanalysis business was divested to Center for Translational Research AB (CTR). David Pekar has since then been the Site Manager and Chief Scientific Officer at Lablytica. As announced by CTR, David will from November 1 2020 be the CEO of Lablytica.
- [Recipharm divests bioanalysis business to Center for Translational Research AB further strengthening existing partnership with CTC Clinical Trial Consultants AB](https://lablytica.com/recipharm-divests-bioanalysis-business-to-center-for-translational-research-ab-further-strengthening-existing-partnership-with-ctc-clinical-trial-consultants-ab/): Recipharm, the contract development and manufacturing organisation, and CTC Clinical Trial Consultants have strengthened their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research AB (CTR) group. CTR is the Uppsala based parent company of CTC Clinical Trial Consultants.

## Sidor
- [Diagnostic Testing](https://lablytica.com/diagnostic-testing/): Lablytica offers diagnostic testing for Therapeutic Drug Monitoring and diagnosis.
- [Careers](https://lablytica.com/careers/): We are a small but diverse group of hands-on analytical chemists located in Uppsala, Sweden. We specialize in both regulated and unregulated analysis of biological samples using ELISA and LC-MS/MS.
- [Cookie Policy](https://lablytica.com/cookie-policy/): We respect your privacy and do not collect any personal information from you when you visit our website. We do not use cookies, trackers, analytics, or any other third-party services that may collect or store your data. We do not ask you to provide any personal information, such as your name, email address, phone number, or location. We do not share or sell your data with anyone.
- [Partners](https://lablytica.com/partners/): Collaborations CTR Group Key Partners
- [Latest news](https://lablytica.com/latest-news/): jun 10, 2025
- [Services](https://lablytica.com/services/): WE KNOW BIOANALYSIS
- [Instrumentation](https://lablytica.com/instrumentation/): Lablytica solely owns all equipment and instrumentation located in our facilities. This ensures that instrument access is never limited by use from other parties.
- [Startpage – Lablytica](https://lablytica.com/): At Lablytica, we offer bioanalytical services to quantify your drug or biomarker in a variety of biological matrices. All method development, validation, and analysis activities at Lablytica utilize fully qualified instruments at our facility in Uppsala, Sweden. Lablytica is fully compliant with OECD GLP and performs method validation and PK sample analysis for preclinical and clinical studies according to ICH M10.
- [Analysis in compliance to OECD GLP](https://lablytica.com/oecd-glp/): The analytical phase of formal GLP studies needs to be performed according to the OECD Series on Principles of Good Laboratory Practice (GLP) and Compliance Monitoring. At Lablytica, method validation and PK study sample analysis is performed according to the ICH M10 guidelines.
- [Bioanalysis in compliance to GCP/GCLP](https://lablytica.com/gcp-gclp/): The bioanalysis of PK samples from clinical trials needs to be performed using validated bioanalytical methods with adherence to the current ICH M10, EMA and FDA guidelines.
- [Biomarker bioanalysis](https://lablytica.com/biomarkers/): The bioanalysis of endogenous biomarkers requires a broad range of expertise. Biomarker molecules vary extensively with respect to concentrations that need to be quantified, the biomarker class, its chemical characteristics, as well as the levels already present in the sample matrix. Another challenge could be that reference material is not available for that analyte.
- [Exploratory](https://lablytica.com/exploratory/): Exploratory analytical projects are usually the first time a method is developed or set-up in the laboratory. Initially, exploratory methods can be used as soon as the sample extraction and instrumental parameters have been developed. This is then enough to obtain initial concentration data from early cell or even animal samples. 
- [About us](https://lablytica.com/about/): Lablytica specializes in bioanalytical services, including sample analysis in plasma, tissue samples, and urine. Research and development activities carried out at our facility in Uppsala, Sweden, are fully compliant with Good Laboratory Practice (GLP) and conform to regulatory guidelines from ICH M10. The laboratory is part of the Swedish OECD GLP regulatory inspection program from SWEDAC.
- [Contact](https://lablytica.com/contact/): For sales and project inquiries please email sales@lablytica.com
- [Privacy Policy](https://lablytica.com/privacy-policy/): This Privacy Policy (the "Privacy Policy") describes how we (Lablytica Life Science AB) obtain and process your personal data. The Privacy Policy also describes your rights in relation to us and how you can assert these rights.